New drug ‘functionally cures’ many hepatitis B virus infections
Short excerpt below. Click through to read at the original source.
GSK’s “bepi” performs better than expected in efficacy trials, but its global impact is likely limited
Short excerpt below. Click through to read at the original source.
GSK’s “bepi” performs better than expected in efficacy trials, but its global impact is likely limited